lymphocytic leukemia
Showing 1 - 11 of 11
Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Beijing (MS-553)
Recruiting
- Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Beijing, Xicheng District, ChinaPeking University People's Hospital
Jun 23, 2022
Symbenda Post-Marketing Surveillance (PMS)
Completed
- Lymphoma, Non-Hodgkin
- +2 more
-
Busan, Korea, Republic of
- +8 more
Jan 25, 2021
Leukemia, Chronic Lymphocytic Leukemia, Lymphocytic Leukemia Trial in Houston (Lirilumab, Rituximab)
Completed
- Leukemia
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 26, 2020
Hodgkin Lymphoma, Lymphocytic Leukemia, Mixed Cell Leukemia Trial run by the NCI (Stem cell transplantation)
Completed
- Hodgkin Lymphoma
- +8 more
- Stem cell transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019
Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (fludarabine/busulfan, fludarabine/
Completed
- Acute Myeloid Leukemia
- +10 more
- fludarabine/busulfan
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago Medical Center
Oct 9, 2018
Factors on Platelet Concentrate Transfusion Response in
Completed
- Lymphoma
- +3 more
- Platelet concentrate transfusion
- (no location specified)
Sep 29, 2017
Lymphocytic Leukemia Trial in Scottsdale, Rochester (alemtuzumab, everolimus)
Completed
- Lymphocytic Leukemia
-
Scottsdale, Arizona
- +1 more
Aug 28, 2017
Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in Lakeland, Tampa (Lenalidomide, Rituximab)
Completed
- Lymphocytic Leukemia
- Mantle Cell Lymphoma
-
Lakeland, Florida
- +1 more
Sep 1, 2015
Lymphocytic Leukemia Trial (Genasense® (, oblimersen sodium G3139))
Withdrawn
- Lymphocytic Leukemia
- Genasense® (, oblimersen sodium G3139)
- (no location specified)
Feb 7, 2008